Andreas Weigert Selected Research

Andreas Weigert Research Topics

Disease

79	Neoplasms (Cancer) 04/2024 - 10/2007
36	Inflammation (Inflammations) 01/2024 - 01/2011
16	Hypoxia (Hypoxemia) 02/2024 - 09/2008
15	Neoplasm Metastasis (Metastasis) 02/2022 - 02/2015
14	Breast Neoplasms (Breast Cancer) 01/2022 - 10/2012
11	Lung Neoplasms (Lung Cancer) 01/2023 - 03/2009
7	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2024 - 01/2017
7	Colitis 02/2022 - 10/2011
6	Atherosclerosis 01/2023 - 01/2009
5	Neuralgia (Stump Neuralgia) 10/2022 - 03/2014
5	Carcinogenesis 07/2021 - 01/2019
5	Sepsis (Septicemia) 03/2020 - 07/2011
4	Colonic Neoplasms (Colon Cancer) 01/2024 - 05/2011
4	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 05/2011
4	Peritonitis 11/2023 - 01/2020
4	Carcinoma (Carcinomatosis) 01/2023 - 01/2019
4	Colitis-Associated Neoplasms 02/2022 - 01/2019
3	Leukemia 04/2024 - 07/2014
3	Pain (Aches) 10/2022 - 03/2014
3	Fibrosis (Cirrhosis) 03/2019 - 01/2019
3	Hyperalgesia 01/2018 - 12/2012
2	Fibrosarcoma 02/2024 - 09/2017
2	Adenocarcinoma 12/2023 - 10/2023
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2023 - 01/2022
2	Urinary Bladder Neoplasms (Bladder Cancer) 11/2023 - 01/2023
2	Acute-On-Chronic Liver Failure 01/2023 - 03/2019
2	Myocardial Infarction 01/2023 - 01/2023
2	Neointima 01/2023 - 01/2021
2	Starvation 12/2022 - 01/2021
2	Neuroinflammatory Diseases 10/2022 - 01/2011
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2022 - 01/2019
2	Necrosis 01/2022 - 10/2013
2	COVID-19 01/2022 - 09/2021
2	Disease Progression 01/2022 - 01/2020

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 02/2024 - 03/2009
18	CytokinesIBA 01/2023 - 08/2010
12	LipidsIBA 04/2024 - 03/2009
11	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2022 - 10/2007
10	EnzymesIBA 01/2024 - 11/2009
10	Dinoprostone (PGE2)FDA Link 11/2023 - 12/2012
9	Lipocalin-2IBA 03/2021 - 12/2011
8	ProstaglandinsIBA 10/2023 - 01/2011
7	Messenger RNA (mRNA)IBA 02/2024 - 09/2009
7	ZymosanIBA 01/2024 - 01/2018
7	RNA (Ribonucleic Acid)IBA 10/2023 - 01/2019
7	Sphingosine-1-Phosphate ReceptorsIBA 01/2019 - 01/2009
6	Imiquimod (Aldara)FDA LinkGeneric 01/2024 - 01/2017
6	Interleukin-1 (Interleukin 1)IBA 01/2022 - 10/2016
6	Conditioned Culture MediaIBA 01/2020 - 10/2007
6	sphingosine kinaseIBA 01/2019 - 01/2009
5	IronIBA 02/2024 - 01/2017
5	SphingolipidsIBA 01/2024 - 01/2019
5	Transcription Factors (Transcription Factor)IBA 01/2022 - 07/2011
5	LigandsIBA 11/2021 - 06/2015
5	Interleukin-12 (IL 12)IBA 10/2020 - 11/2009
5	Interleukin-10 (Interleukin 10)IBA 01/2020 - 11/2009
4	Dextrans (Dextran)FDA Link 02/2022 - 10/2011
4	Prostaglandin-E SynthasesIBA 01/2022 - 01/2011
4	Interleukin-17 (Interleukin 17)IBA 01/2021 - 01/2019
4	MicroRNAs (MicroRNA)IBA 01/2021 - 07/2017
4	InterleukinsIBA 07/2020 - 01/2013
4	Prostaglandins EIBA 10/2013 - 01/2011
3	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2022
3	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2020
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2024 - 01/2020
3	dihydroceramide desaturaseIBA 01/2024 - 01/2017
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 10/2014
3	AntigensIBA 01/2023 - 01/2009
3	AzoxymethaneIBA 02/2022 - 01/2018
3	Tamoxifen FDA LinkGeneric 01/2022 - 12/2019
3	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 07/2021 - 01/2019
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2020 - 01/2018
3	Phosphotransferases (Kinase)IBA 07/2020 - 10/2017
3	sodium sulfate (sodium bisulfate)FDA LinkGeneric 07/2020 - 10/2011
3	Interleukin-27 (Interleukin 27)IBA 01/2020 - 06/2012
3	Neutralizing AntibodiesIBA 01/2020 - 01/2016
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 09/2008
3	Oxygen (Dioxygen)IBA 10/2018 - 09/2008
3	Interleukin-6 (Interleukin 6)IBA 10/2017 - 01/2013
2	PhosphatidylserinesIBA 04/2024 - 01/2022
2	Small Interfering RNA (siRNA)IBA 02/2024 - 03/2009
2	LeukotrienesIBA 01/2024 - 01/2018
2	Interleukin-4 (Interleukin 4)IBA 01/2024 - 01/2018
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2023 - 10/2013
2	Meloxicam (Mobic)FDA LinkGeneric 10/2023 - 03/2014
2	Sirolimus (Rapamycin)FDA Link 12/2022 - 10/2017
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2022 - 07/2021
2	Cyclooxygenase InhibitorsIBA 01/2022 - 03/2014
2	AntibodiesIBA 09/2021 - 01/2020
2	Epoxy Compounds (Epoxides)IBA 07/2021 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 10/2013

Therapy/Procedure

25	Therapeutics 10/2023 - 01/2009
8	Immunotherapy 04/2024 - 01/2009
5	Ligation 12/2019 - 07/2011
4	Punctures 01/2019 - 07/2011
3	Drug Therapy (Chemotherapy) 10/2022 - 01/2020
2	Adjuvant Chemotherapy 11/2023 - 01/2023
2	Chemoradiotherapy 01/2023 - 01/2022
2	Radiotherapy 01/2023 - 06/2012
2	Neoadjuvant Therapy 01/2022 - 01/2022